1532 related articles for article (PubMed ID: 26099262)
1. Quantitative determination of two polymorphic forms of imatinib mesylate in a drug substance and tablet formulation by X-ray powder diffraction, differential scanning calorimetry and attenuated total reflectance Fourier transform infrared spectroscopy.
Bellur Atici E; Karlığa B
J Pharm Biomed Anal; 2015 Oct; 114():330-40. PubMed ID: 26099262
[TBL] [Abstract][Full Text] [Related]
2. Quantification of febuxostat polymorphs using powder X-ray diffraction technique.
Qiu JB; Li G; Sheng Y; Zhu MR
J Pharm Biomed Anal; 2015 Mar; 107():298-303. PubMed ID: 25636167
[TBL] [Abstract][Full Text] [Related]
3. Quantitative determination of polymorphic impurity by X-ray powder diffractometry in an OROS formulation.
Varasteh M; Deng Z; Hwang H; Kim YJ; Wong GB
Int J Pharm; 2009 Jan; 366(1-2):74-81. PubMed ID: 18840515
[TBL] [Abstract][Full Text] [Related]
4. Quantification of polymorphic impurity in an enantiotropic polymorph system using differential scanning calorimetry, X-ray powder diffraction and Raman spectroscopy.
Li Y; Chow PS; Tan RB
Int J Pharm; 2011 Aug; 415(1-2):110-8. PubMed ID: 21645601
[TBL] [Abstract][Full Text] [Related]
5. Quantitation of polymorphic impurity in entecavir polymorphic mixtures using powder X-ray diffractometry and Raman spectroscopy.
Kang Y; Shao Z; Wang Q; Hu X; Yu D
J Pharm Biomed Anal; 2018 Sep; 158():28-37. PubMed ID: 29857267
[TBL] [Abstract][Full Text] [Related]
6. Quantification of olanzapine polymorphs using powder X-ray diffraction technique.
Tiwari M; Chawla G; Bansal AK
J Pharm Biomed Anal; 2007 Feb; 43(3):865-72. PubMed ID: 17034979
[TBL] [Abstract][Full Text] [Related]
7. Quantification of Losartan Potassium Polymorphs Using Powder X-Ray Diffraction.
Lou Y; Zuo L
J AOAC Int; 2021 Jun; 104(3):579-584. PubMed ID: 33337486
[TBL] [Abstract][Full Text] [Related]
8. Solid state characterization of azelnidipine-oxalic acid co-crystal and co-amorphous complexes: The effect of different azelnidipine polymorphs.
Pan Y; Pang W; Lv J; Wang J; Yang C; Guo W
J Pharm Biomed Anal; 2017 May; 138():302-315. PubMed ID: 28237872
[TBL] [Abstract][Full Text] [Related]
9. Determination of the polymorphic forms of bicifadine hydrochloride by differential scanning calorimetry-thermogravimetric analysis, X-ray powder diffraction, attenuated total reflectance-infrared spectroscopy, and attenuated total reflectance-near-infrared spectroscopy.
McArdle P; Gilligan K; Cunningham D; Ryder A
Appl Spectrosc; 2005 Nov; 59(11):1365-71. PubMed ID: 16316514
[TBL] [Abstract][Full Text] [Related]
10. Quantification of gabapentin polymorphs in gabapentin/excipient mixtures using solid state
Tinmanee R; Larsen SC; Morris KR; Kirsch LE
J Pharm Biomed Anal; 2017 Nov; 146():29-36. PubMed ID: 28843174
[TBL] [Abstract][Full Text] [Related]
11. Evaluation and correlation of the physicochemical properties of carvedilol.
Alves JM; Prado LD; Rocha HV
Pharm Dev Technol; 2016 Nov; 21(7):856-866. PubMed ID: 26336079
[TBL] [Abstract][Full Text] [Related]
12. Comprehensive spectroscopic characterization of finasteride polymorphic forms. Does the form X exist?
Frelek J; Górecki M; Dziedzic A; Jabłońska E; Kamieński B; Wojcieszczyk RK; Luboradzki R; Szczepek WJ
J Pharm Sci; 2015 May; 104(5):1650-7. PubMed ID: 25648836
[TBL] [Abstract][Full Text] [Related]
13. Polymorphism in nimodipine raw materials: development and validation of a quantitative method through differential scanning calorimetry.
Riekes MK; Pereira RN; Rauber GS; Cuffini SL; de Campos CE; Silva MA; Stulzer HK
J Pharm Biomed Anal; 2012 Nov; 70():188-93. PubMed ID: 22795312
[TBL] [Abstract][Full Text] [Related]
14. Characterization and quantitation of aprepitant drug substance polymorphs by attenuated total reflectance fourier transform infrared spectroscopy.
Helmy R; Zhou GX; Chen YW; Crocker L; Wang T; Wenslow RM; Vailaya A
Anal Chem; 2003 Feb; 75(3):605-11. PubMed ID: 12585491
[TBL] [Abstract][Full Text] [Related]
15. Solid-State Characterization of Spironolactone 1/3 Hydrate.
Lemos Barbosa TW; Doriguetto AC; Benjamim de Araújo M; Bonfilio R
J Pharm Sci; 2019 Jul; 108(7):2458-2464. PubMed ID: 30853514
[TBL] [Abstract][Full Text] [Related]
16. Effect of sample preparation method on quantification of polymorphs using PXRD.
Alam S; Patel S; Bansal AK
Pharm Dev Technol; 2010; 15(5):452-9. PubMed ID: 19842910
[TBL] [Abstract][Full Text] [Related]
17. Preparation and characterization of a novel polymorph of indiplon, Form α.
Xu L; Wang J; Xiao B; Yang J; Liu Y; Huang R
Bioorg Med Chem Lett; 2012 Jan; 22(2):963-8. PubMed ID: 22209207
[TBL] [Abstract][Full Text] [Related]
18. Resveratrol cocrystals with enhanced solubility and tabletability.
Zhou Z; Li W; Sun WJ; Lu T; Tong HHY; Sun CC; Zheng Y
Int J Pharm; 2016 Jul; 509(1-2):391-399. PubMed ID: 27282539
[TBL] [Abstract][Full Text] [Related]
19. Indomethacin: new polymorphs of an old drug.
Surwase SA; Boetker JP; Saville D; Boyd BJ; Gordon KC; Peltonen L; Strachan CJ
Mol Pharm; 2013 Dec; 10(12):4472-80. PubMed ID: 24025118
[TBL] [Abstract][Full Text] [Related]
20. The polymorph landscape of dabigatran etexilate mesylate: Taking the challenge to bring a metastable polymorph to market.
Sieger P; Werthmann U; Saouane S
Eur J Pharm Sci; 2023 Jul; 186():106447. PubMed ID: 37044200
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
